Ładuje się......
Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin
BACKGROUND: The EphA2 receptor, which is expressed in many types of cancer, is activated by two different mechanisms. Activation by engagement with one of its ephrin ligands is anti-oncogenic whereas phosphorylation of S897 by AKT increases migration, invasion and metastasis. Down-regulation of clau...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2014
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4212103/ https://ncbi.nlm.nih.gov/pubmed/25344320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-014-0059-5 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|